Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05746650 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Improving Tissue Repair After Injury in the Muscle-tendon Interface Muscle Tissue Injury

Study acronym: GH-MTJ
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Notable Primary completion date: Jun 1, 2025 to Jun 1, 2027
    • Study completion date: Sep 1, 2025 to Sep 1, 2027
    v5
  2. Notable Primary completion date: Mar 1, 2024 to Jun 1, 2025
    • Study completion date: Mar 1, 2025 to Sep 1, 2025
    v4
  3. Notable Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Mar 1, 2023 to Feb 24, 2023
    v3
  4. Minor Interventions: Control (No electrical stimulation, nor growth hormone) (Other), Electrical stimulation (Other), Growth hormone (somatropin) (Other) to Control (No electrical stimulation, nor growth hormone) (Other), Electrical stimulation (Procedure), Growth hormone (somatropin) (Drug)
    • Secondary endpoints: details revised at 5 of 8 entries
    v2
  5. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study is a 2-week human study where 40 patients who are scheduled to undergo reconstructive knee surgery are randomized to administration of GH or placebo following or without neuromuscular electrical stimulation of hamstring muscles.The overall aim is to determine, the role of muscle connective tissue protein synthesis in muscle injury and repair.
Trial Details
NCT Number NCT05746650
Lead Sponsor Bispebjerg Hospital
Conditions
(from sponsor)
Muscle Injury
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov